Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

J.P. Morgan Sticks to Their Hold Rating for Sanofi (SNYNF)

Tipranks - Tipranks - Tue Mar 31, 1:04AM CDT

In a report released today, Richard Vosser from J.P. Morgan maintained a Hold rating on Sanofi, with a price target of €95.00.

End of Quarter Sale - 50% Off TipRanks

Vosser covers the Healthcare sector, focusing on stocks such as Novo Nordisk, Roche Holding AG, and Sanofi. According to TipRanks, Vosser has an average return of 0.5% and a 45.23% success rate on recommended stocks.

In addition to J.P. Morgan, Sanofi also received a Hold from TipRanks – xAI’s xAi Drug Manufacturers – General in a report issued on March 26. However, on the same day, Deutsche Bank maintained a Buy rating on Sanofi (Other OTC: SNYNF).

See the top stocks recommended by analysts >>

The company has a one-year high of €103.64 and a one-year low of €74.85. Currently, Sanofi has an average volume of 2.39M.

Read More on SNYNF:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).